Nano based-oncolytic viruses for cancer therapy

Area of Science:

• Oncology
• Nanomedicine
• Virology

Background:

• Oncolytic viruses (OV) offer a dual mechanism for cancer treatment: direct tumor cell lysis and immune response stimulation.
• Systemic delivery of OVs faces challenges, primarily elimination by the reticuloendothelial system.
• Nanoparticles (NPs) are utilized in cancer therapy but struggle with non-specific delivery and rapid clearance from circulation.

Purpose of the Study:

• To review the mechanisms of oncolytic viruses and nanoparticles in cancer therapy.
• To explore the challenges associated with systemic delivery of OVs and NPs.
• To highlight the synergistic potential of encapsulating OVs within NPs for enhanced cancer treatment.

Main Methods:

• Review of existing literature on oncolytic virus therapy.
• Analysis of nanoparticle applications in drug delivery for cancer.
• Examination of strategies for modifying nanoparticle surfaces to improve drug delivery efficiency.
• Investigation of the combined approach of OV-loaded nanoparticles in preclinical and clinical studies.

Main Results:

• Oncolytic viruses demonstrate direct tumor cell killing and immune modulation.
• Nanoparticles offer unique characteristics for drug delivery but require surface modifications for improved targeting and circulation time.
• Encapsulating OVs within NPs has shown successful clinical outcomes in treating various cancers, overcoming individual limitations.

Conclusions:

• The combination of OVs and NPs represents a promising strategy for advanced cancer therapy.
• Encapsulation of OVs within NPs enhances their therapeutic efficacy and overcomes delivery hurdles.
• Further research into OV-NP complexes could lead to more effective and targeted cancer treatments.